Segueing between preclinical and clinical data
Finding the right cell/right compartment isn't easy - it requires persistence and dedication
Hats off to companies pursuing an emerging target in breast cancer
A discussion of some of the key topics emerging in ER+ HER2- breast cancer
W2W4 on the TPD front
Review of some of the key trials in breast cancer being showcased in Paris next month
Key posters of interest at ESMO21
A look at a wide array of targets, modalities, new agents and companies through the lens of targeted therapies
